• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远志皂苷 D 通过 NF-κB 抑制甲状腺乳头状癌细胞的恶性进展,并增强帕博利珠单抗的治疗效果。

Platycodin D inhibits the malignant progression of papillary thyroid carcinoma by NF-κB and enhances the therapeutic efficacy of pembrolizumab.

机构信息

Hepatobiliary Pancreas, Breast and Thyroid Surgery Ward, The People's Hospital of Kaizhou District, Chongqing, China.

Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Drug Dev Res. 2022 May;83(3):708-720. doi: 10.1002/ddr.21902. Epub 2021 Dec 3.

DOI:10.1002/ddr.21902
PMID:34859901
Abstract

Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid cancer. Studies have shown that platycodin D has several pharmacological effects like anti-inflammatory, immunomodulatory, and anti-tumor effects, while the effect and mechanism of platycodin D on PTC are still unclear. This study was designed to investigate the effects of platycodin D on PTC by a series of in vitro and in vivo experiments. The results revealed that platycodin D inhibits PTC cell viability and clonal levels and affects PTC cell cycle. Platycodin D promotes apoptosis in PTC cells. Furthermore, it inhibits the activation of NF-κB signaling pathway and affects cell growth. Platycodin D inhibits PD-L1 expression and enhances the effect of pembrolizumab on PTC cells. In conclusion, platycodin D can effectively block the progression of PTC through the NF-κB signaling pathway, accompanied by cell cycle arrest and enhanced cell apoptosis. In vitro and in vivo, platycodin D was shown to enhance pembrolizumab's sensitivity to PTC. Platycodin D is a promising monomer for therapy of PTC, providing references for future research on PTC treatment.

摘要

甲状腺乳头状癌(PTC)是最常见的甲状腺癌病理类型。研究表明,桔梗皂苷 D 具有抗炎、免疫调节和抗肿瘤等多种药理作用,而桔梗皂苷 D 对 PTC 的作用及机制尚不清楚。本研究通过一系列的体外和体内实验,旨在探讨桔梗皂苷 D 对 PTC 的影响。结果表明,桔梗皂苷 D 抑制 PTC 细胞活力和集落水平,并影响 PTC 细胞周期。桔梗皂苷 D 促进 PTC 细胞凋亡。此外,它还抑制 NF-κB 信号通路的激活,影响细胞生长。桔梗皂苷 D 抑制 PD-L1 的表达,增强了 pembrolizumab 对 PTC 细胞的作用。综上所述,桔梗皂苷 D 能有效通过 NF-κB 信号通路阻断 PTC 的进展,同时伴有细胞周期阻滞和增强细胞凋亡。在体外和体内,桔梗皂苷 D 均显示出增强 pembrolizumab 对 PTC 的敏感性。桔梗皂苷 D 是治疗 PTC 的一种很有前途的单体,为 PTC 治疗的未来研究提供了参考。

相似文献

1
Platycodin D inhibits the malignant progression of papillary thyroid carcinoma by NF-κB and enhances the therapeutic efficacy of pembrolizumab.远志皂苷 D 通过 NF-κB 抑制甲状腺乳头状癌细胞的恶性进展,并增强帕博利珠单抗的治疗效果。
Drug Dev Res. 2022 May;83(3):708-720. doi: 10.1002/ddr.21902. Epub 2021 Dec 3.
2
LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.LDOC1通过抑制甲状腺乳头状癌中NF-κB的激活来抑制增殖并促进凋亡。
J Exp Clin Cancer Res. 2015 Dec 4;34:146. doi: 10.1186/s13046-015-0265-z.
3
MiR-145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF-κB pathway regulation.miR-145 通过调控 NF-κB 通路抑制甲状腺乳头状癌细胞的迁移和侵袭。
J Cell Biochem. 2020 Jun;121(5-6):3325-3332. doi: 10.1002/jcb.29604. Epub 2020 Jan 7.
4
Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.桔梗皂苷D通过激活核因子-κB诱导永生化角质形成细胞凋亡。
Eur J Pharmacol. 2006 May 10;537(1-3):1-11. doi: 10.1016/j.ejphar.2006.03.012. Epub 2006 Mar 20.
5
BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.BRAFV600E 和 RET/PTC 通过调节核因子-κB 促进甲状腺乳头状癌细胞的增殖和迁移。
Med Sci Monit. 2017 Nov 8;23:5321-5329. doi: 10.12659/msm.904928.
6
Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, suppresses the growth and invasion of human oral squamous cell carcinoma cells via the NF-κB pathway.桔梗皂苷D,一种来自桔梗的三萜皂苷,通过NF-κB途径抑制人口腔鳞状细胞癌细胞的生长和侵袭。
J Biochem Mol Toxicol. 2017 Sep;31(9). doi: 10.1002/jbt.21934. Epub 2017 May 26.
7
SYTL5 Promotes Papillary Thyroid Carcinoma Progression by Enhancing Activation of the NF-κB Signaling Pathway.SYTL5 通过增强 NF-κB 信号通路的激活促进甲状腺乳头状癌细胞的进展。
Endocrinology. 2022 Nov 14;164(1). doi: 10.1210/endocr/bqac187.
8
KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.受miR-548b-3p调控的KPNA4促进甲状腺乳头状癌的恶性表型。
Life Sci. 2021 Jan 15;265:118743. doi: 10.1016/j.lfs.2020.118743. Epub 2020 Nov 11.
9
Punicalagin induces senescent growth arrest in human papillary thyroid carcinoma BCPAP cells via NF-κB signaling pathway.鞣花酸通过 NF-κB 信号通路诱导人甲状腺乳头状癌细胞 BCPAP 衰老性生长停滞。
Biomed Pharmacother. 2018 Jul;103:490-498. doi: 10.1016/j.biopha.2018.04.074. Epub 2018 Apr 24.
10
MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.MicroRNA-146a 通过靶向 PRKCE 调节甲状腺乳头状瘤的发展。
Int J Cancer. 2014 Jan 15;134(2):257-67. doi: 10.1002/ijc.28141. Epub 2013 Sep 18.

引用本文的文献

1
Silibinin Anticancer Effects Through the Modulation of the Tumor Immune Microenvironment in Triple-Negative Breast Cancer.水飞蓟宾通过调节三阴性乳腺癌肿瘤免疫微环境发挥抗癌作用。
Int J Mol Sci. 2025 Jun 28;26(13):6265. doi: 10.3390/ijms26136265.
2
KLF4 mediates the contradictory effects of phenylethyl isothiocyanate in gastric cancer intervention.KLF4介导异硫氰酸苯乙酯在胃癌干预中的矛盾作用。
Med Oncol. 2025 Jun 12;42(7):253. doi: 10.1007/s12032-025-02795-1.
3
Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in Thyroid Cancer Cells.
积雪草苷通过下调 HIF-1α 抑制甲状腺癌细胞的增殖、迁移和血管生成。
Balkan Med J. 2024 Jan 3;41(1):23-29. doi: 10.4274/balkanmedj.galenos.2023.2023-7-123. Epub 2023 Dec 4.
4
PD-L1 Expression and Ultrasound Characteristics in Papillary Thyroid Carcinoma and Its Effect on Recurrence.PD-L1 表达与甲状腺乳头状癌的超声特征及其对复发的影响。
In Vivo. 2023 Nov-Dec;37(6):2820-2828. doi: 10.21873/invivo.13396.